1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Custom Antibody Services Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Custom Antibody Services Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Custom Antibody Services Market Regional Analysis
6.2 Europe Custom Antibody Services Market Revenue 2021-2031 (US$ Million)
6.3 Europe Custom Antibody Services Market Forecast Analysis
7. Europe Custom Antibody Services Market Analysis – by Product Type
7.1 Monoclonal
- 7.1.1 Overview
- 7.1.2 Monoclonal: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Polyclonal Hybridoma
- 7.2.1 Overview
- 7.2.2 Polyclonal Hybridoma: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Recombinant Antibody
- 7.3.1 Overview
- 7.3.2 Recombinant Antibody: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Europe Custom Antibody Services Market Analysis – by Service Type
8.1 Antibody Discovery and Development
- 8.1.1 Overview
- 8.1.2 Antibody Discovery and Development: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Antibody Production Services
- 8.2.1 Overview
- 8.2.2 Antibody Production Services: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Europe Custom Antibody Services Market Analysis – by Disease Indication
9.1 Oncology
- 9.1.1 Overview
- 9.1.2 Oncology: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Infectious Diseases
- 9.2.1 Overview
- 9.2.2 Infectious Diseases: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Immunology
- 9.3.1 Overview
- 9.3.2 Immunology: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Cardiovascular Diseases
- 9.4.1 Overview
- 9.4.2 Cardiovascular Diseases: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Europe Custom Antibody Services Market Analysis – by Source
10.1 Chicken
- 10.1.1 Overview
- 10.1.2 Chicken: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.2 Rabbits
- 10.2.1 Overview
- 10.2.2 Rabbits: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.3 Rats
- 10.3.1 Overview
- 10.3.2 Rats: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.4 Guinea Pigs
- 10.4.1 Overview
- 10.4.2 Guinea Pigs: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.5 Mouse or Humanized Mice
- 10.5.1 Overview
- 10.5.2 Mouse or Humanized Mice: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
10.6 Others
- 10.6.1 Overview
- 10.6.2 Others: Europe Custom Antibody Services Market – Revenue and Forecast, 2021-2031 (US$ Million)
11. Europe Custom Antibody Services Market – Europe Analysis
11.1 Overview
11.2 Europe
- 11.2.1 Europe Custom Antibody Services Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 11.2.1.1 Europe Custom Antibody Services Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 Germany:
Europe Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.1.1 Germany: Europe Custom Antibody Services Market Breakdown, by Product Type
- 11.2.1.1.2 Germany: Europe Custom Antibody Services Market Breakdown, by Service Type
- 11.2.1.1.3 Germany: Europe Custom Antibody Services Market Breakdown, by Disease Indication
- 11.2.1.1.4 Germany: Europe Custom Antibody Services Market Breakdown, by Source
- 11.2.1.2 France:
Europe Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.2.1 France: Europe Custom Antibody Services Market Breakdown, by Product Type
- 11.2.1.2.2 France: Europe Custom Antibody Services Market Breakdown, by Service Type
- 11.2.1.2.3 France: Europe Custom Antibody Services Market Breakdown, by Disease Indication
- 11.2.1.2.4 France: Europe Custom Antibody Services Market Breakdown, by Source
- 11.2.1.3 Italy:
Europe Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.3.1 Italy: Europe Custom Antibody Services Market Breakdown, by Product Type
- 11.2.1.3.2 Italy: Europe Custom Antibody Services Market Breakdown, by Service Type
- 11.2.1.3.3 Italy: Europe Custom Antibody Services Market Breakdown, by Disease Indication
- 11.2.1.3.4 Italy: Europe Custom Antibody Services Market Breakdown, by Source
- 11.2.1.4 UK:
Europe Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.4.1 UK: Europe Custom Antibody Services Market Breakdown, by Product Type
- 11.2.1.4.2 UK: Europe Custom Antibody Services Market Breakdown, by Service Type
- 11.2.1.4.3 UK: Europe Custom Antibody Services Market Breakdown, by Disease Indication
- 11.2.1.4.4 UK: Europe Custom Antibody Services Market Breakdown, by Source
- 11.2.1.5 Spain:
Europe Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.5.1 Spain: Europe Custom Antibody Services Market Breakdown, by Product Type
- 11.2.1.5.2 Spain: Europe Custom Antibody Services Market Breakdown, by Service Type
- 11.2.1.5.3 Spain: Europe Custom Antibody Services Market Breakdown, by Disease Indication
- 11.2.1.5.4 Spain: Europe Custom Antibody Services Market Breakdown, by Source
- 11.2.1.6 Rest of Europe:
Europe Custom Antibody Services Market – Revenue and Forecast to 2031 (US$ Million)
- 11.2.1.6.1 Rest of Europe: Europe Custom Antibody Services Market Breakdown, by Product Type
- 11.2.1.6.2 Rest of Europe: Europe Custom Antibody Services Market Breakdown, by Service Type
- 11.2.1.6.3 Rest of Europe: Europe Custom Antibody Services Market Breakdown, by Disease Indication
- 11.2.1.6.4 Rest of Europe: Europe Custom Antibody Services Market Breakdown, by Source
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Thermo Fisher Scientific Inc
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Sino Biological Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 GenScript Biotech Corporation
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Biochain Incorporated
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 R&D Systems, Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Kaneka Eurogentec S.A.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Fortis Life Sciences
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Precision Antibody (A&G Pharmaceutical, Inc.)
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Biocytogen Pharmaceuticals Beijing Co Ltd
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Abgenex
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
14.11 Creative Biolabs Inc
- 14.11.1 Key Facts
- 14.11.2 Business Description
- 14.11.3 Products and Services
- 14.11.4 Financial Overview
- 14.11.5 SWOT Analysis
- 14.11.6 Key Developments
14.12 Agilent Technologies Inc
- 14.12.1 Key Facts
- 14.12.2 Business Description
- 14.12.3 Products and Services
- 14.12.4 Financial Overview
- 14.12.5 SWOT Analysis
- 14.12.6 Key Developments
14.13 Bioklone
- 14.13.1 Key Facts
- 14.13.2 Business Description
- 14.13.3 Products and Services
- 14.13.4 Financial Overview
- 14.13.5 SWOT Analysis
- 14.13.6 Key Developments
14.14 Scantibodies Laboratory, Inc.
- 14.14.1 Key Facts
- 14.14.2 Business Description
- 14.14.3 Products and Services
- 14.14.4 Financial Overview
- 14.14.5 SWOT Analysis
- 14.14.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations